GPT Healthcare Ltd

- The transcript from the conference call does not mention any current or planned fundraising through debt or equity. - There is no discussion about raising capital through new debt instruments or equity offerings. - The company is focusing on organic growth, expansion via new hospitals (e.g., Jamshedpur), and possible acquisitions or greenfield projects predominantly in Eastern India's Tier 2 cities. - Investment plans involve deploying capital for new hospital launches and refurbishments, but no explicit comments on funding sources or fundraising strategies were provided.

- GPT Healthcare Limited has signed an MOU for a new hospital in Jamshedpur with a planned capacity of 150 beds. - Estimated investment outlay for the Jamshedpur hospital is INR 70 crores. - The Jamshedpur hospital is expected to be commissioned by the end of Q3 FY '27. - The company is actively evaluating multiple cities in Eastern India for inorganic or organic growth opportunities, including Varanasi, Patna, and Cuttack. - Preference for asset-light models (leased land), but willing to invest in land if the location is strategic. - The company aims to become a 1,000-bed hospital chain over the next two years, reflecting ongoing expansion plans. - No specific new capex amounts disclosed besides the Jamshedpur project investment.

- The company is guiding for a 15% overall top-line growth for the current year. - Growth rates of 20%-25% are unlikely as mature hospitals typically grow at 6%-8%; 15% growth is expected with new hospital additions (Page 10). - Base business growth excluding new hospitals like Raipur is around 6%-6.5%, on track with previous commitments (Page 6). - Ramp-up of new hospitals like Raipur is anticipated; occupancy expected to reach 25%-35% over the year with EBITDA margins of 8%-10% (Pages 9-10). - Addition of Jamshedpur hospital expected by end of FY '27, incurring INR4-5 crores losses initially but contributing to growth long-term (Page 9). - Strategies like optimizing department mix and shortening average length of stay (from 5.8 to 4.3 days) aim to improve throughput and revenues (Page 8). - ARPOB growth guidance of 5%-6% driven by case mix and price increases supports revenue growth (Page 5).

- GPT Healthcare expects overall top-line growth around 15% with new hospital additions. - Mature hospitals typically experience 6-8% growth; newer hospitals have higher growth rates initially. - EBITDA margins for FY '26 projected around 20-22% (including other income), with mature hospitals at ~25% margin before HO costs. - Raipur hospital expected to reach breakeven monthly around 12-15 months at ~25-35% occupancy, with FY '27 EBITDA margin of 8-10%. - New hospital Jamshedpur to be commissioned by end FY '27, expecting INR4-5 crores loss initially. - ARPOB (average revenue per occupied bed) growth guided at 5-6% annually through rate revisions and improved case mix. - EBITDA losses of about INR9-10 crores expected per full year for newly commissioned hospitals initially but improve over time. - The company aims to become a 1,000-bed hospital chain within two years, indicating steady operational scaling and profit growth.

The provided transcript from GPT Healthcare Limited's Q2 FY26 earnings call does not explicitly mention details about the current or expected order book or pending orders. The discussion primarily focuses on operational performance, hospital occupancies, margins, new hospital projects (like Jamshedpur and Raipur), growth outlook, and acquisition plans. Key related points: - Signed an MOU for a new hospital in Jamshedpur (150 beds, INR70 crores investment), expected commissioning by end Q3 FY27. - Actively evaluating multiple cities including Varanasi, Patna, and Cuttack for expansion (greenfield or asset-light models). - Challenges in acquiring good-quality assets in Tier 2 cities; exploring greenfield options. - No specific mention of order book or pending order values. Thus, no direct data on orderbook or pending orders is available in the transcript.